Key facts
- This page summarizes Michael C. James's Form 4 filing for GUIDED THERAPEUTICS INC (GTHP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 07 Apr 2026, 13:53.
Michael C. James - 10 Mar 2026 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)
- Reporting relationship
- Director
- Issuer ticker
- GTHP
- Reported as of
- 10 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Apr 2026, 13:53:55 UTC
- Prior SEC filing
- 04 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael C James
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael C. James filed Form 4 for GUIDED THERAPEUTICS INC (GTHP) on 07 Apr 2026.
Change
- Previous filing in this sequence was filed on 04 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001365831
Primary reporting owner
JAMES MICHAEL C
- Relationship
- Director
- Address
- 5835 PEACHTREE CORNERS, SUITE B, PEACHTREE CORNERS
- Signature
- /s/ Michael C James
- Signature date
- 07 Apr 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GTHP
transaction
Derivative
Stock Options
Award
- Transaction value
- Shares
- +110,000
- Change %
- Price
- $0.000000*
- Shares after
- 110,000
- Date
- 10 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 110,000
- Exercise price
- $0.2900
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
One-fourth of the shares subject to the award vested on March 10, 2026; the remaining shares will vest monthly, starting on June 10, 2026, subject to the reporting person's continued service on each such date, until the award is fully vested on March 10, 2029.